Dietary flaxseed oil reduces adipocyte size, adipose monocyte chemoattractant protein-1 levels and T-cell infiltration in obese, insulin-resistant rats

Cytokine

Volumn 59, Issue 2, 2012, Pages 382-391

  Baranowski, Maria ^a   Enns, Jennifer ^a,b   Blewett, Heather ^b   Yakandawala, Uma ^a   Zahradka, Peter ^a,b   Taylor, Carla G ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ST BONIFACE GENERAL HOSPITAL   (Canada)

Author keywords

Adipose tissue dysfunction; Inflammation; MCP 1; Obesity; Omega 3 fatty acid

Indexed keywords

ADIPONECTIN; GAMMA INTERFERON; HAPTOGLOBIN; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LEPTIN; LINOLEIC ACID; LINSEED OIL; MONOCYTE CHEMOTACTIC PROTEIN 1; OMEGA 3 FATTY ACID; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CELL ISOLATION; CELL SIZE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; DIGITAL IMAGING; DOWN REGULATION; EX VIVO STUDY; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; LINSEED; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RAT; SPLEEN CELL; T LYMPHOCYTE; THERAPY EFFECT; TISSUE LEVEL; TISSUE SECTION; TREATMENT DURATION; ZUCKER RAT;

ADIPOCYTES; ADIPOKINES; ADIPOSE TISSUE; ANIMALS; BODY WEIGHT; CELL MOVEMENT; CELL SIZE; CHEMOKINE CCL2; CYTOKINES; DIETARY FATS, UNSATURATED; FATTY ACIDS; HAPTOGLOBINS; INFLAMMATION; INSULIN RESISTANCE; LINSEED OIL; MACROPHAGES; MALE; OBESITY; ORGAN SIZE; PHENOTYPE; PHOSPHOLIPIDS; RATS; RATS, ZUCKER; SPLEEN; T-LYMPHOCYTES;

RATTUS;

EID: 84862336760     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.04.004     Document Type: Article

References (66)

1. Bastard J.P., Maachi M., Lagathu C., Kim M.J., Caron M., Vidal H., et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006, 17(1):4-12.
2. Fogarty A.W., Glancy C., Jones S., Lewis S.A., McKeever T.M., Britton J.R. A prospective study of weight change and systemic inflammation over 9y. Am J Clin Nutr 2008, 87(1):30-35.
3. Navab M., Gharavi N., Watson A.D. Inflammation and metabolic disorders. Curr Opin Clin Nutr Metab Care 2008, 11(4):459-464.
4. Falagas M.E., Kompoti M. Obesity and infection. Lancet Infect Dis 2006, 6(7):438-446.
5. Fernandez-Riejos P., Najib S., Santos-Alvarez J., Martin-Romero C., Perez-Perez A., Gonzalez-Yanes C., et al. Role of leptin in the activation of immune cells. Mediators Inflamm 2010, 2010:568343.
6. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112(12):1796-1808.
7. Voll R.E., Urbonaviciute V. High mobility group box 1 in the pathogenesis of inflammatory and autoimmune diseases. Israel Med Assoc J 2008, 10:26-28.
8. Lolmede K., Duffaut C., Zakaroff-Girard A., Bouloumie A. Immune cells in adipose tissue: key players in metabolic disorders. Diabetes Metab 2011, 37(4):283-290.
9. Kintscher U., Hartge M., Hess K., Foryst-Ludwig A., Clemenz M., Wabitsch M., et al. T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol 2008, 28(7):1304-1310.
10. Pizato N., Bonatto S., Piconcelli M., de Souza L.M., Sassaki G.L., Naliwaiko K., et al. Fish oil alters T-lymphocyte proliferation and macrophage responses in walker 256 tumor-bearing rats. Nutrition 2006, 22(4):425-432.
11. Thies F., Nebe-von-Caron G., Powell J.R., Yaqoob P., Newsholme E.A., Calder P.C. Dietary supplementation with gamma-linolenic acid or fish oil decreases T lymphocyte proliferation in healthy older humans. J Nutr 2001, 131(7):1918-1927.
12. Zhang P., Smith R., Chapkin R.S., McMurray D.N. Dietary (n-3) polyunsaturated fatty acids modulate murine Th1/Th2 balance toward the Th2 pole by suppression of Th1 development. J Nutr 2005, 135(7):1745-1751.
13. Reseland J.E., Haugen F., Hollung K., Solvoll K., Halvorsen B., Brude I.R., et al. Reduction of leptin gene expression by dietary polyunsaturated fatty acids. J Lipid Res 2001, 42(5):743-750.
14. Wang H., Storlien L.H., Huang X.F. Effects of dietary fat types on body fatness, leptin, and ARC leptin receptor, NPY, and AgRP mRNA expression. Am J Physiol Endocrinol Metab 2002, 282(6):E1352-E1359.
15. Kratz M., von Eckardstein A., Fobker M., Buyken A., Posny N., Schulte H., et al. The impact of dietary fat composition on serum leptin concentrations in healthy nonobese men and women. J Clin Endocrinol Metab 2002, 87(11):5008-5014.
16. Pischon T., Hankinson S.E., Hotamisligil G.S., Rifai N., Willett W.C., Rimm E.B. Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation 2003, 108(2):155-160.
17. Lopez-Garcia E., Schulze M.B., Manson J.E., Meigs J.B., Albert C.M., Rifai N., et al. Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 2004, 134(7):1806-1811.
18. Zhao G., Etherton T.D., Martin K.R., West S.G., Gillies P.J., Kris-Etherton P.M. Dietary alpha-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. J Nutr 2004, 134(11):2991-2997.
19. Bemelmans W.J., Lefrandt J.D., Feskens E.J., van Haelst P.L., Broer J., Meyboom-de Jong B., et al. Increased alpha-linolenic acid intake lowers C-reactive protein, but has no effect on markers of atherosclerosis. Eur J Clin Nutr 2004, 58(7):1083-1089.
20. Rallidis L.S., Paschos G., Liakos G.K., Velissaridou A.H., Anastasiadis G., Zampelas A. Dietary alpha-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients. Atherosclerosis 2003, 167(2):237-242.
21. Merchant A.T., Curhan G.C., Rimm E.B., Willett W.C., Fawzi W.W. Intake of n-6 and n-3 fatty acids and fish and risk of community-acquired pneumonia in US men. Am J Clin Nutr 2005, 82(3):668-674.
22. Wall R., Ross R.P., Fitzgerald G.F., Stanton C. Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev 2010, 68(5):280-289.
23. Shimizu H., Oh-I S., Okada S., Mori M. Leptin resistance and obesity. Endocr J 2007, 54(1):17-26.
24. Reeves P.G. Components of the AIN-93 diets as improvements in the AIN-76A diet. J Nutr 1997, 127(Suppl. 5):838S-841S.
25. Canadian Council on Animal Care. Guide to the care and use of experimental animals. November 28, 2008.
26. Noto A., Zahradka P., Yurkova N., Xie X., Truong H., Nitschmann E., et al. Dietary conjugated linoleic acid decreases adipocyte size and favorably modifies adipokine status and insulin sensitivity in obese, insulin-resistant rats. Metabolism 2007, 56(12):1601-1611.
27. Yau L., Elliot T., Lalonde C., Zahradka P. Repression of phosphoenolpyruvate carboxykinase gene activity by insulin is blocked by 3-aminobenzamide but not by PD128763, a selective inhibitor of poly(ADP-ribose) polymerase. Eur J Biochem 1998, 253(1):91-100.
28. Noto A., Zahradka P., Ryz N.R., Yurkova N., Xie X., Taylor C.G. Dietary conjugated linoleic acid preserves pancreatic function and reduces inflammatory markers in obese, insulin-resistant rats. Metabolism 2007, 56(1):142-151.
29. Parrish C.C., Pathy D.A., Parkes J.G., Angel A. Dietary fish oils modify adipocyte structure and function. J Cell Physiol 1991, 148(3):493-502.
30. Fickova M., Hubert P., Cremel G., Leray C. Dietary (n-3) and (n-6) polyunsaturated fatty acids rapidly modify fatty acid composition and insulin effects in rat adipocytes. J Nutr 1998, 128(3):512-519.
31. Huber J., Loffler M., Bilban M., Reimers M., Kadl A., Todoric J., et al. Prevention of high-fat diet-induced adipose tissue remodeling in obese diabetic mice by n-3 polyunsaturated fatty acids. Int J Obes (Lond) 2007, 31(6):1004-1013.
32. Gillam M., Noto A., Zahradka P., Taylor C.G. Improved n-3 fatty acid status does not modulate insulin resistance in fa/fa zucker rats. Prostaglandins Leukot Essent Fatty Acids 2009, 81(5-6):331-339.
33. Sell H., Eckel J. Adipose tissue inflammation: novel insight into the role of macrophages and lymphocytes. Curr Opin Clin Nutr Metab Care 2010, 13(4):366-370.
34. Caspar-Bauguil S., Cousin B., Galinier A., Segafredo C., Nibbelink M., Andre M., et al. Adipose tissues as an ancestral immune organ: site-specific change in obesity. FEBS Lett 2005, 579(17):3487-3492.
35. Wu H., Ghosh S., Perrard X.D., Feng L., Garcia G.E., Perrard J.L., et al. T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation 2007, 115(8):1029-1038.
36. Rausch M.E., Weisberg S., Vardhana P., Tortoriello D.V. Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration. Int J Obes (Lond) 2008, 32(3):451-463.
37. Rocha V.Z., Folco E.J., Sukhova G., Shimizu K., Gotsman I., Vernon A.H., et al. Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ Res 2008, 103(5):467-476.
38. Bour S., Caspar-Bauguil S., Iffiu-Soltesz Z., Nibbelink M., Cousin B., Miiluniemi M., et al. Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 deficiency reduces leukocyte infiltration into adipose tissue and favors fat deposition. Am J Pathol 2009, 174(3):1075-1083.
39. Kanda H., Tateya S., Tamori Y., Kotani K., Hiasa K., Kitazawa R., et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006, 116(6):1494-1505.
40. Yoshizaki T., Schenk S., Imamura T., Babendure J.L., Sonoda N., Bae E.J., et al. SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity. Am J Physiol Endocrinol Metab 2010, 298(3):E419-E428.
41. Munoz M.C., Giani J.F., Dominici F.P., Turyn D., Toblli J.E. Long-term treatment with an angiotensin II receptor blocker decreases adipocyte size and improves insulin signaling in obese zucker rats. J Hypertens 2009, 27(12):2409-2420.
42. Manickam E., Sinclair A.J., Cameron-Smith D. Suppressive actions of eicosapentaenoic acid on lipid droplet formation in 3T3-L1 adipocytes. Lipids Health Dis 2010, 9:57.
43. de Ferranti S., Mozaffarian D. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem 2008, 54(6):945-955.
44. Skopkova M., Penesova A., Sell H., Radikova Z., Vlcek M., Imrich R., et al. Protein array reveals differentially expressed proteins in subcutaneous adipose tissue in obesity. Obesity (Silver Spring) 2007, 15(10):2396-2406.
45. Moore C.S., Bryant S.P., Mishra G.D., Krebs J.D., Browning L.M., Miller G.J., et al. Oily fish reduces plasma triacylglycerols: Aa primary prevention study in overweight men and women. Nutrition 2006, 22(10):1012-1024.
46. Paschos G.K., Zampelas A., Panagiotakos D.B., Katsiougiannis S., Griffin B.A., Votteas V., et al. Effects of flaxseed oil supplementation on plasma adiponectin levels in dyslipidemic men. Eur J Nutr 2007, 46(6):315-320.
47. Nelson T.L., Stevens J.R., Hickey M.S. Adiponectin levels are reduced, independent of polymorphisms in the adiponectin gene, after supplementation with alpha-linolenic acid among healthy adults. Metabolism 2007, 56(9):1209-1215.
48. Kratz M., Swarbrick M.M., Callahan H.S., Matthys C.C., Havel P.J., Weigle D.S. Effect of dietary n-3 polyunsaturated fatty acids on plasma total and high-molecular-weight adiponectin concentrations in overweight to moderately obese men and women. Am J Clin Nutr 2008, 87(2):347-353.
49. Sowers J.R. Endocrine functions of adipose tissue: Focus on adiponectin. Clin Cornerstone 2008, 9(1):32-38. discussion 39-40.
50. DeClercq V., Taylor C.G., Zahradka P. Isomer-specific effects of conjugated linoleic acid on blood pressure, adipocyte size and function. Br J Nutr 2012, 107:1413-1421.
51. de Assis S., Wang M., Goel S., Foxworth A., Helferich W., Hilakivi-Clarke L. Excessive weight gain during pregnancy increases carcinogen-induced mammary tumorigenesis in sprague-dawley and lean and obese zucker rats. J Nutr 2006, 136(4):998-1004.
52. Honnma H., Endo T., Kiya T., Shimizu A., Nagasawa K., Baba T., et al. Remarkable features of ovarian morphology and reproductive hormones in insulin-resistant zucker fatty (fa/fa) rats. Reprod Biol Endocrinol 2010, 8:73.
53. Belobrajdic D.P., Lam Y.Y., Mano M., Wittert G.A., Bird A.R. Cereal based diets modulate some markers of oxidative stress and inflammation in lean and obese zucker rats. Nutr Metab (Lond) 2011, 8:27.
54. Barbu A., Hedlund G.P., Lind J., Carlsson C. Pref-1 and adipokine expression in adipose tissues of GK and zucker rats. Mol Cell Endocrinol 2009, 299(2):163-171.
55. Bluher M. The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol 2010, 21(1):38-43.
56. Wildman R.P., Muntner P., Reynolds K., McGinn A.P., Rajpathak S., Wylie-Rosett J., et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: Prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008, 168(15):1617-1624.
57. Farb M.G., Bigornia S., Mott M., Tanriverdi K., Morin K.M., Freedman J.E., et al. Reduced adipose tissue inflammation represents an intermediate cardiometabolic phenotype in obesity. J Am Coll Cardiol 2011, 58(3):232-237.
58. Peterson L.D., Jeffery N.M., Thies F., Sanderson P., Newsholme E.A., Calder P.C. Eicosapentaenoic and docosahexaenoic acids alter rat spleen leukocyte fatty acid composition and prostaglandin E2 production but have different effects on lymphocyte functions and cell-mediated immunity. Lipids 1998, 33(2):171-180.
59. Ruth M.R., Proctor S.D., Field C.J. Feeding long-chain n-3 polyunsaturated fatty acids to obese leptin receptor-deficient JCR:LA - cp rats modifies immune function and lipid-raft fatty acid composition. Br J Nutr 2009, 101(9):1341-1350.
60. Goldman D.W., Pickett W.C., Goetzl E.J. Human neutrophil chemotactic and degranulating activities of leukotriene B5 (LTB5) derived from eicosapentaenoic acid. Biochem Biophys Res Commun 1983, 117(1):282-288.
61. Lee T.H., Mencia-Huerta J.M., Shih C., Corey E.J., Lewis R.A., Austen K.F. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. J Clin Invest 1984, 74(6):1922-1933.
62. Bagga D., Wang L., Farias-Eisner R., Glaspy J.A., Reddy S.T. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci U S A 2003, 100(4):1751-1756.
63. Serhan C.N., Hong S., Gronert K., Colgan S.P., Devchand P.R., Mirick G., et al. Resolvins: A family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 2002, 196(8):1025-1037.
64. Serhan C.N., Clish C.B., Brannon J., Colgan S.P., Chiang N., Gronert K. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med 2000, 192(8):1197-1204.
65. Arita M., Yoshida M., Hong S., Tjonahen E., Glickman J.N., Petasis N.A., et al. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc Natl Acad Sci U S A 2005, 102(21):7671-7676.
66. McMurray D.N., Jolly C.A., Chapkin R.S. Effects of dietary n-3 fatty acids on T cell activation and T cell receptor-mediated signaling in a murine model. J Infect Dis 2000, 182(Suppl. 1):S103-S107.